A detailed history of Gemmer Asset Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gemmer Asset Management LLC holds 1,040 shares of LLY stock, worth $851,614. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,040
Previous 1,047 0.67%
Holding current value
$851,614
Previous $947,000 2.75%
% of portfolio
0.1%
Previous 0.1%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $5,404 - $6,720
-7 Reduced 0.67%
1,040 $921,000
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $16,672 - $20,907
23 Added 2.25%
1,047 $947,000
Q4 2023

Jan 17, 2024

SELL
$525.19 - $619.13 $165,960 - $195,645
-316 Reduced 23.58%
1,024 $596,000
Q3 2023

Oct 18, 2023

BUY
$434.7 - $599.3 $255,168 - $351,789
587 Added 77.95%
1,340 $719,000
Q3 2022

Oct 21, 2022

BUY
$296.48 - $337.87 $223,249 - $254,416
753 New
753 $243,000
Q2 2022

Jul 22, 2022

SELL
$278.73 - $327.27 $154,137 - $180,980
-553 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$234.69 - $291.66 $12,203 - $15,166
-52 Reduced 8.6%
553 $158,000
Q2 2021

Jul 23, 2021

SELL
$180.55 - $233.54 $14,082 - $18,216
-78 Reduced 11.42%
605 $139,000
Q1 2021

Apr 20, 2021

BUY
$164.32 - $212.72 $14,788 - $19,144
90 Added 15.18%
683 $128,000
Q3 2019

Oct 11, 2019

SELL
$106.79 - $116.16 $29,367 - $31,944
-275 Reduced 31.68%
593 $66,000
Q1 2019

Apr 17, 2019

SELL
$111.31 - $131.02 $27,716 - $32,623
-249 Reduced 22.29%
868 $113,000
Q4 2018

Jan 18, 2019

BUY
$105.9 - $118.64 $17,685 - $19,812
167 Added 17.58%
1,117 $129,000
Q4 2017

Jan 16, 2018

BUY
$81.94 - $87.89 $24,582 - $26,367
300 Added 46.15%
950 $80,000
Q3 2017

Oct 12, 2017

BUY
$77.07 - $85.54 $50,095 - $55,601
650
650 $56,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $778B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.